The use of staurosporine analogues for enhancing neurotrophin activity
The staurosporine analogues BE-13793C, a monosaccharide derivative thereof, rebeccamycin and NB-506 are indicated for new therapeutic uses in conditions of neuronal degeneration such as Alzheimer's, Huntington's corea, epilepsy, and brain or spinal cord injuries. The compounds are believed...
Saved in:
Main Authors | , , |
---|---|
Format | Patent |
Language | English |
Published |
01.12.1999
|
Edition | 6 |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The staurosporine analogues BE-13793C, a monosaccharide derivative thereof, rebeccamycin and NB-506 are indicated for new therapeutic uses in conditions of neuronal degeneration such as Alzheimer's, Huntington's corea, epilepsy, and brain or spinal cord injuries. The compounds are believed to potertrate neurotrophin-3 (NT-3) action without unhibiting tyrosine kinase (Trk). |
---|---|
AbstractList | The staurosporine analogues BE-13793C, a monosaccharide derivative thereof, rebeccamycin and NB-506 are indicated for new therapeutic uses in conditions of neuronal degeneration such as Alzheimer's, Huntington's corea, epilepsy, and brain or spinal cord injuries. The compounds are believed to potertrate neurotrophin-3 (NT-3) action without unhibiting tyrosine kinase (Trk). |
Author | HOWARD BARFF BROUGHTON SCOTT JEFFREY POLLACK SARAH JANE HARPER |
Author_xml | – fullname: HOWARD BARFF BROUGHTON – fullname: SCOTT JEFFREY POLLACK – fullname: SARAH JANE HARPER |
BookMark | eNqFyjsKAjEQBuAUWvg6g3MBQTbF1iquHmD7ZQh_NoFlJuQheHst7K2-5tualahgY4YxgFoBqadSuWUtSXMUEAsvOjcU8poJElhclJkE31SzphCF2NX4ivW9N2vPS8Hh584ch_t4e56QdEJJ7CCo0-PaWdv35-5i_48Pxyw1Mw |
ContentType | Patent |
DBID | EVB |
DatabaseName | esp@cenet |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Sciences |
Edition | 6 |
ExternalDocumentID | GB2337702A |
GroupedDBID | EVB |
ID | FETCH-epo_espacenet_GB2337702A3 |
IEDL.DBID | EVB |
IngestDate | Fri Jul 19 12:45:47 EDT 2024 |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-epo_espacenet_GB2337702A3 |
Notes | Application Number: GB19990012318 |
OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=19991201&DB=EPODOC&CC=GB&NR=2337702A |
ParticipantIDs | epo_espacenet_GB2337702A |
PublicationCentury | 1900 |
PublicationDate | 19991201 |
PublicationDateYYYYMMDD | 1999-12-01 |
PublicationDate_xml | – month: 12 year: 1999 text: 19991201 day: 01 |
PublicationDecade | 1990 |
PublicationYear | 1999 |
RelatedCompanies | MERCK SHARP & DOHME LIMITED |
RelatedCompanies_xml | – name: MERCK SHARP & DOHME LIMITED |
Score | 2.5126398 |
Snippet | The staurosporine analogues BE-13793C, a monosaccharide derivative thereof, rebeccamycin and NB-506 are indicated for new therapeutic uses in conditions of... |
SourceID | epo |
SourceType | Open Access Repository |
SubjectTerms | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES |
Title | The use of staurosporine analogues for enhancing neurotrophin activity |
URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=19991201&DB=EPODOC&locale=&CC=GB&NR=2337702A |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV07T8MwED6VgoANCqi8PaBsEcVx22SIEEmaVkh9CBXUrYodh3ZxoiYVf5-zaYGlm2VLJz90_k7n-z4DPDgs7cgkkTZ3KbOZzJ5sTzjSTiiCpZukGTU53eGoM3hnr7P2rAaLLRfG6IR-GXFE9CiB_l6Z-7r4S2JFprayfORL7Mqf46kfWemGLuY9IaBZUeD3JuNoHFph6PcDa_TmU8fpdlv0ZQ_2dRCtVfZ7H4HmpBT_ASU-gYMJ2lLVKdSkasBRuP13rQGHw81zNzY3nleeQYznSdalJHlGMKDTIpSFrp2TJFE_-ZeSYPxJpFpoBQ31SYxSZbXKi8VSEU1f0L9EnMN93JuGAxsnNP9d-7wfbGfuXEBd5Uo2gWQic4UjhOfyFksRdNuaOSUYZ5R7XcovobnLytXuoWs4NpoEplbjBurVai1vEXErfmc26xuvDYfL |
link.rule.ids | 230,309,786,891,25594,76904 |
linkProvider | European Patent Office |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV3NT8IwFH9BNOJNUYOf9GB2W4SusO2wGLcxUPmKQeONrF0nXLqFjfjv21ZQL9yaNnnpR15_7ev7_QpwZ5Gky-OYm9TBxCQ8bZsus7gZYwmWTpykWMd0R-Pu4I08f3Q-KrDYcmG0TuiXFkeUHsWkv5d6v87_glihzq0s7ulSVmUP0cwLjWRDF3PbEtCM0Pd600k4CYwg8Pq-MX71sGXZdgs_7sG-LS-ESmW_9-4rTkr-H1CiYziYSluiPIEKF3WoBdt_1-pwONo8d8vixvOKU4jkeqJ1wVGWInmgUyKUucqd4ygWP_GXAsnzJ-JioRQ0xCfSSpXlKssXS4EUfUH9EnEGzag3Cwam7ND8d-zzvr_tuXUOVZEJ3gCUstRhFmOuQ1skkaDbUcwpRijB1LUxvYDGLiuXu5uaUBvMRsP58Gn8cgVHWp9A521cQ7VcrfmNRN-S3uqJ-wYuVoq2 |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=The+use+of+staurosporine+analogues+for+enhancing+neurotrophin+activity&rft.inventor=HOWARD+BARFF+BROUGHTON&rft.inventor=SCOTT+JEFFREY+POLLACK&rft.inventor=SARAH+JANE+HARPER&rft.date=1999-12-01&rft.externalDBID=A&rft.externalDocID=GB2337702A |